Retracted: Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV‐1‐infected T lymphocytes in vitro

Retraction: The following article has been retracted through agreement between the first author and several coauthors, the journal Editor‐in‐Chief, Peter Lichter, and John Wiley & Sons, Ltd.: Tomita, M., Tanaka, Y. and Mori, N. (2010), Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV‐1‐infected T lymphocytes in vitro. Int J Cancer, 127:1584–1594, published online on 20 JAN 2010 in Wiley Online Library (www.onlinelibrary.wiley.com). After an investigation the retraction has been agreed due to inappropriate duplication of images and overlap with other published work.

[1]  M. Furihata,et al.  Analysis of Aurora B kinase in non-Hodgkin lymphoma , 2009, Laboratory Investigation.

[2]  P. Opolon,et al.  The Aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe , 2009, Cell cycle.

[3]  M. Toyota,et al.  Retracted: Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV‐1‐infected T cells through enhanced NF‐κB activity , 2009, International journal of cancer.

[4]  J. Fitzgibbon,et al.  AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo. , 2009, Cancer research.

[5]  J. Pollard,et al.  Discovery and development of aurora kinase inhibitors as anticancer agents. , 2009, Journal of medicinal chemistry.

[6]  Oliver Gautschi,et al.  Aurora Kinases as Anticancer Drug Targets , 2008, Clinical Cancer Research.

[7]  Tony Reiman,et al.  The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma , 2008, British journal of haematology.

[8]  L. Galluzzi,et al.  Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway , 2007, PloS one.

[9]  J. Bourhis,et al.  Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152 , 2007, Oncogene.

[10]  Rajesh Odedra,et al.  AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis , 2007, Clinical Cancer Research.

[11]  Kuan-Teh Jeang,et al.  Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation , 2007, Nature Reviews Cancer.

[12]  N. Keen,et al.  Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase. , 2007, Journal of medicinal chemistry.

[13]  G. Schwartz,et al.  Aurora Kinases: New Targets for Cancer Therapy , 2006, Clinical Cancer Research.

[14]  B. Sullivan,et al.  Regulation of mitotic chromosome cohesion by Haspin and Aurora B. , 2006, Developmental cell.

[15]  M. Loda,et al.  The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. , 2006, Cancer research.

[16]  D. Ballinari,et al.  PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity , 2006, Clinical Cancer Research.

[17]  J. Schellens,et al.  Phase I and pharmacological study of the novel aurora kinase inhibitor AZD1152. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Tang,et al.  Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis. , 2006, Developmental biology.

[19]  Stephen S. Taylor,et al.  Aurora-kinase inhibitors as anticancer agents , 2004, Nature Reviews Cancer.

[20]  J. Choe,et al.  The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor β signaling through interaction with CREB-binding protein , 2004, Oncogene.

[21]  J. Brady,et al.  Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1 , 2004, Oncogene.

[22]  David Bebbington,et al.  VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo , 2004, Nature Medicine.

[23]  Erich A Nigg,et al.  Aurora kinases link chromosome segregation and cell division to cancer susceptibility. , 2004, Current opinion in genetics & development.

[24]  W. Earnshaw,et al.  The cellular geography of Aurora kinases , 2003, Nature Reviews Molecular Cell Biology.

[25]  Meeting abstracts , 2003 .

[26]  Stephen S. Taylor,et al.  Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores , 2003, The Journal of cell biology.

[27]  J. Peters,et al.  The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint , 2003, The Journal of cell biology.

[28]  R. Margolis,et al.  G1 tetraploidy checkpoint and the suppression of tumorigenesis , 2003, Journal of cellular biochemistry.

[29]  M. Tomonaga,et al.  Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells , 1999 .

[30]  M. Tomonaga,et al.  Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells , 1999 .

[31]  Brian Schryver,et al.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.

[32]  M. Ishiyama,et al.  A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. , 1996, Biological & pharmaceutical bulletin.

[33]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[34]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[35]  Yuetsu Tanaka,et al.  Heterogeneity of Antigen Molecules Recognized by Anti‐tax1 Monoclonal Antibody Lt‐4 in Cell Lines Bearing Human T Cell Leukemia Virus Type I and Related Retroviruses , 1990, Japanese journal of cancer research : Gann.

[36]  H. Saya,et al.  Aurora-A — A guardian of poles , 2005, Nature Reviews Cancer.